These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21324561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP, Niedzwiecki D, Johnson JL.
    N Engl J Med; 2009 Dec 10; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract] [Full Text] [Related]

  • 3. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Busia A, Laffranchi A, Viviani S, Bonfante V, Villani F.
    Anticancer Res; 2010 Oct 10; 30(10):4381-7. PubMed ID: 21036768
    [Abstract] [Full Text] [Related]

  • 4. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P, Bonadonna G.
    Haematologica; 1998 Sep 10; 83(9):769-70. PubMed ID: 9825571
    [No Abstract] [Full Text] [Related]

  • 5. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F, Busia A, Villani M, Laffranchi A, Viviani S, Bonfante V.
    Anticancer Res; 2009 Feb 10; 29(2):777-83. PubMed ID: 19331235
    [Abstract] [Full Text] [Related]

  • 6. Hodgkin's disease: controversies and challenges for the future.
    Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL.
    Haematologica; 1991 Feb 10; 76(4):263-79. PubMed ID: 1724436
    [No Abstract] [Full Text] [Related]

  • 7. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract] [Full Text] [Related]

  • 8. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of advanced Hodgkin lymphoma].
    Kreissl S, Borchmann P.
    Dtsch Med Wochenschr; 2013 Jun 01; 138(23):1212-4. PubMed ID: 23720173
    [No Abstract] [Full Text] [Related]

  • 10. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
    Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J, Ho A, Dörken B, Rank A, Grosu AL, Wiegel T, Karstens JH, Greil R, Willich N, Schmidberger H, Döhner H, Borchmann P, Müller-Hermelink HK, Müller RP, Engert A.
    J Clin Oncol; 2010 Sep 20; 28(27):4199-206. PubMed ID: 20713848
    [Abstract] [Full Text] [Related]

  • 11. [Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs].
    Leszko B, Słomkowski M, Przybyszewska M, Apel D, Pawelski S.
    Acta Haematol Pol; 1986 Sep 20; 17(3-4):81-90. PubMed ID: 2438894
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H.
    Cancer Treat Res; 1989 Sep 20; 41():241-6. PubMed ID: 2484293
    [No Abstract] [Full Text] [Related]

  • 13. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
    Castelo-Branco C, Nomdedeu B, Camus A, Mercadal S, Martínez de Osaba MJ, Balasch J.
    Fertil Steril; 2007 Mar 20; 87(3):702-5. PubMed ID: 17173900
    [Abstract] [Full Text] [Related]

  • 14. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
    Brosteanu O, Hasenclever D, Loeffler M, Diehl V, German Hodgkin's Lymphoma Study Group.
    Ann Hematol; 2004 Mar 20; 83(3):176-82. PubMed ID: 15064867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemotherapy for Hodgkin's disease.
    Ekert H.
    N Engl J Med; 2003 Sep 18; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of chemotherapy in the management of early stage Hodgkin's disease.
    Rosenberg SA.
    Hematol Oncol; 1984 Sep 18; 2(1):61-3. PubMed ID: 6203821
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.